1. Search Result
Search Result
Results for "

99614-02-5

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

4

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0002B
    Ondansetron
    Maximum Cited Publications
    8 Publications Verification

    GR 38032; SN 307

    5-HT Receptor Neurological Disease Cancer
    Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity .
    Ondansetron
  • HY-B0002BS

    GR 38032-d5; SN 307-d5

    5-HT Receptor Neurological Disease
    Ondansetron-d5 is the deuterium labeled Ondansetron. Ondansetron (GR 38032; SN 307) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.
    Ondansetron-d5
  • HY-B0002S

    Isotope-Labeled Compounds 5-HT Receptor Neurological Disease
    Ondansetron-d3 (hydrochloride) is the deuterium labeled Ondansetron hydrochloride. Ondansetron hydrochloride (GR 38032 hydrochloride) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy[1][2].
    Ondansetron-d3 hydrochloride
  • HY-B0002
    Ondansetron hydrochloride
    Maximum Cited Publications
    8 Publications Verification

    GR 38032 hydrochloride; SN 307 hydrochloride

    5-HT Receptor Neurological Disease
    Ondansetron hydrochloride (GR 38032 hydrochloride; SN 307 hydrochloride) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.
    Ondansetron hydrochloride
  • HY-B0002A
    Ondansetron hydrochloride dihydrate
    Maximum Cited Publications
    8 Publications Verification

    GR 38032 hydrochloride dihydrate; SN 307 hydrochloride dihydrate

    5-HT Receptor Neurological Disease Cancer
    Ondansetron (GR 38032) hydrochloride dehydrate is an orally active, highly selective and competitive 5-HT3 receptor antagonist (crosses the blood-brain barrier). Ondansetron hydrochloride dehydrate can be used in studies of preventing nausea and vomiting associated with cancer chemotherapy, radiation therapy and surgery .
    Ondansetron hydrochloride dihydrate
  • HY-B0002BR

    5-HT Receptor Neurological Disease Cancer
    Ondansetron (Standard) is the analytical standard of Ondansetron. This product is intended for research and analytical applications. Ondansetron (GR 38032; SN 307) is a highly selective 5-HT3 receptor antagonist, with IC50 value of 103 pM. Ondansetron exerts antiemetic effects by antagonizing 5-HT receptor located on local neurons in the peripheral and central nervous system. Ondansetron suppresses nausea and vomiting caused by chemotherapy and radiation therapy. Ondansetron has orally bioactivity .
    Ondansetron (Standard)
  • HY-B0002BS2

    GR 38032-13C,d3; SN 307-13C,d3

    Isotope-Labeled Compounds 5-HT Receptor Neurological Disease
    Ondansetron- 13C,d3 is the 13C- and deuterium labeled Ondansetron[1].
    Ondansetron-13C,d3
  • HY-B0002BS1

    GR 38032-d3; SN 307-d3

    5-HT Receptor Neurological Disease
    Ondansetron-d3 is the deuterium labeled Ondansetron[1]. Ondansetron(GR 38032;SN 307) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy[2].
    Ondansetron-d3

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: